ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 273,12
2,37%
Dow Jones
40 524,79
0,78%
DAX
20 954,83
2,88%
Brent Oil
64,655
0,22%
Bitcoin
85 029,35
0,53%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Avalo Therapeutics Inc (AVTX)

  7. Avalo Therapeutics Inc (AVTX) Actualités

AVTX

Avalo Therapeutics (AVTX)

Avalo Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AVTX
DateHeureSourceTitreSymboleSociété
02/04/202502h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
26/03/202512h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
26/03/202512h00GlobeNewswire Inc.Avalo Therapeutics Appoints Michael Heffernan as Chairman of the BoardNASDAQ:AVTXAvalo Therapeutics Inc
20/03/202512h06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AVTXAvalo Therapeutics Inc
20/03/202512h00GlobeNewswire Inc.Avalo Reports 2024 Financial Results and Recent Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
24/02/202513h00GlobeNewswire Inc.Avalo Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:AVTXAvalo Therapeutics Inc
04/02/202514h00GlobeNewswire Inc.Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences ConferenceNASDAQ:AVTXAvalo Therapeutics Inc
03/01/202522h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
02/01/202513h00GlobeNewswire Inc.Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy OfficerNASDAQ:AVTXAvalo Therapeutics Inc
31/12/202422h13Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AVTXAvalo Therapeutics Inc
14/11/202418h05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
12/11/202413h00GlobeNewswire Inc.Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement WarrantsNASDAQ:AVTXAvalo Therapeutics Inc
11/11/202413h00GlobeNewswire Inc.Avalo Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:AVTXAvalo Therapeutics Inc
07/11/202413h20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVTXAvalo Therapeutics Inc
07/11/202413h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVTXAvalo Therapeutics Inc
07/11/202413h00GlobeNewswire Inc.Avalo Reports Third Quarter 2024 Financial Results and Recent Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
08/10/202413h00GlobeNewswire Inc.Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis SuppurativaNASDAQ:AVTXAvalo Therapeutics Inc
08/10/202402h06Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AVTXAvalo Therapeutics Inc
04/09/202413h00GlobeNewswire Inc.Avalo Announces Participation in September Investor ConferencesNASDAQ:AVTXAvalo Therapeutics Inc
12/08/202413h00GlobeNewswire Inc.Avalo Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
06/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AVTXAvalo Therapeutics Inc
05/08/202422h36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:AVTXAvalo Therapeutics Inc
29/07/202422h08Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
16/07/202413h00GlobeNewswire Inc.Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical OfficerNASDAQ:AVTXAvalo Therapeutics Inc
11/07/202422h12Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
24/06/202422h01GlobeNewswire Inc.Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal OfficerNASDAQ:AVTXAvalo Therapeutics Inc
17/06/202413h30GlobeNewswire Inc.Avalo to Present at the Oppenheimer Novel Targets in Immunology SummitNASDAQ:AVTXAvalo Therapeutics Inc
07/06/202413h01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AVTXAvalo Therapeutics Inc
06/06/202422h03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AVTXAvalo Therapeutics Inc
03/06/202413h20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AVTX

Dernières Valeurs Consultées

AMEX
LABU
Direxion Daily S&P Biote...
AMEX
GRPM
Invesco S&p Midcap 400 G...
AMEX
ANEW
Proshares MSCI Transform...
AMEX
AMZP
Kurv Yield Premium Strat...
BIT
NSCIT59058G8
International Bank for R...
NYSE
FVRR
Fiverr
NASDAQ
PDD
PDD
AMEX
AAPX
T Rex 2X Long Apple Dail...
NYSE
NOAH
Noah
AMEX
VIOO
Vanguard S&P Small Cap 600
AMEX
IBLC
iShares Blockchain and T...
AMEX
ACWV
iShares MSCI Global Min ...
AMEX
QEFA
SPDR MSCI EAFE Strategic...
COIN
BARTTUSD
BIT
NSCIT4654108
Prospectus Italy
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces